title: Using "rationally designed drugs" rationally.
authors.affiliation: Dana Farber Cancer Institute, Boston, MA 02115, USA. james_brugarolas@dfci.harvard.edu <james_brugarolas@dfci.harvard.edu>
authors.forename: Jim
authors.initials: J
authors.lastname: Brugarolas
authors.forename: Jeffrey W
authors.initials: JW
authors.lastname: Clark
authors.forename: Bruce
authors.initials: B
authors.lastname: Chabner
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D002986:Clinical Trials as Topic / Q000379:methods; D015195:Drug Design; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D009369:Neoplasms / Q000145:classification / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D018579:Patient Selection; D015203:Reproducibility of Results; D012107:Research Design
chemical_list: D000970:Antineoplastic Agents